Welcome to MaineLifeScience.com
MaineLifeScience.com is part of a specialized network of state- and province-based biotechnology, medical device,
and life science sites that includes more than 4,500 biotechnology, medical device, pharmaceutical companies,
non-profit research institutions, universities and supporting service sector companies across the U.S. and Canada.
This network addresses the growing informational and service needs of companies, patients, educators and others in
their respective states while providing clients the opportunity to cost effectively
advertise their job openings, events, facility availability and other services at the state level,
regionally or nationwide. We welcome your comments, suggestions and requests for informational content and supporting
services.
 More...
Destination Maine
Are you considering a move to Maine? Relocating your business to
Maine? Starting a company? Or just interested in Maine?
This section will answer many of your questions regarding the life science industry in Maine, the province's
economy, tax structure and cost of living, education, transportation, climate, recreational opportunities, history,
industry resources, and more.
More...
|
|
|
Local News...
Free News Release Posting & Archiving Service
- Implant Sciences receives $750,000 contract award from Department of Homeland Security Implant Sciences announced the award of a thirteen month, $750,000 Phase II Small Business Innovation Research contract by the Department of Homeland Security, Science & Technology Directorate in Washington, DC for the delivery of a handheld trace explosives sampler.
Implant Sciences Corporation October 06, 2008
- Bristol-Myers Squibb comments on Eli Lilly as new Erbitux marketing partner Eli Lilly and Company announced that it will acquire ImClone Systems for $70 per share, or approximately $6.5 billion. Bristol-Myers Squibb Company currently owns approximately 16.6 percent of all outstanding shares of ImClone.
Bristol-Myers Squibb Company October 06, 2008
- FDA accepts ATryn(R) BLA filing; GTC receives $2 million in milestone payments The US Food and Drug Administration, or FDA, has accepted for review GTC Biotherapeutics Biologics License Application, or BLA, for ATryn(R). FDA's Blood Products Advisory Committee intends to review the BLA for ATryn(R) during a meeting that is being planned for January 2009.
GTC Biotherapeutics, Inc. October 06, 2008
- ARIAD announces favorable ruling permitting immediate appeal of district court findings ARIAD Pharmaceuticals announced that the U.S. District Court for the District of Delaware granted ARIAD's motion to permit an immediate appeal of the Court's summary judgment ruling of non-infringement by Amgen's drug, Enbrel(R) (etanercept), of seven claims of U.S. Patent No. 6,410,516.
ARIAD Pharmaceuticals, Inc. October 06, 2008
- Idera announces issuance of patents for novel immune modulatory oligonucleotides Idera Pharmaceuticals announced the issuance of patents covering its novel immune modulatory oligonucleotides (IMO), chemical modifications of IMOs, and methods of inducing an immune response through administering such compounds.
Idera Pharmaceuticals, Inc. October 06, 2008
More... | Submit News Release | National News
|
New Job Postings...
Free Job Posting Trial Offer
More... |
Job Advertising...
| About Job Postings...
|
New Facilities Available...
ATC clean room constructors...validation guaranteed!
More... |
Facility Advertising...
|
Upcoming Events...
Free Event Posting Service
 More... |
Submit Event |
Event Advertising...
|
|
Learn About Maine's BioHistory
Why is there a biotechnology industry in Maine? Will the industry continue
to grow in Maine? What do other states have? Each state has a unique story
that explains why a given industry has developed in a specific region and not in others.
Through Maine BioHistory, you can learn about the scientists,
institutions, political leaders, and significant events that have shaped and are still shaping
the biotechnology, medical device and life science industries in the state of Maine.
More...
BioEvolution Posters
More...
Flu Season is Here: Learn How to Protect Yourself and Your Loved Ones
Influenza, also called flu, is a contagious respiratory illness caused by
influenza viruses. It can cause mild to severe illness, and at times can lead
to death. The best way to prevent the flu is by getting a flu vaccination each
year.
October through December is the best time to get vaccinated, but getting
vaccinated later in the flu season still provides protection, as flu season
normally peaks in January or later.
More...
BioFact
(1928) - Sir Alexander Fleming observes a culture of mold inhibiting growth of Staphylococcus bacteria in a petri dish. He names this mold penicillin.
It's a Small World
|
| |
Organic Cells
| |
Science Quote
"The most incomprehensible thing about our universe is that it can be comprehended."
| - |
Albert Einstein
|
|
(1879-1955)
|
|
